Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1985 Mar;53(3):253–259. doi: 10.1136/hrt.53.3.253

Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.

M Been, D P de Bono, A L Muir, F E Boulton, W S Hillis, R Hornung
PMCID: PMC481752  PMID: 3882107

Abstract

BRL 26921 is a protected plasminogen-streptokinase complex with selective affinity for thrombus. When given intravenously within three hours of the onset of a first acute myocardial infarction angiographic patency of the infarct related vessel was seen in all 16 patients receiving the active drug compared with only two of 16 receiving a placebo. There was relative sparing of left ventricular function in the active treatment group with anterior infarction (mean left ventricular ejection fraction 37% compared with 23% for placebo), but no significant difference in left ventricular function between the active and placebo groups was seen in patients with inferior infarction. Intravenous BRL 26921 is highly effective in causing coronary reperfusion and may help to preserve left ventricular function when given early in the course of anterior infarction.

Full text

PDF
254

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Marshall H. W., Bray B. E., Lutz J. R., Frederick P. R., Yanowitz F. G., Datz F. L., Klausner S. C., Hagan A. D. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med. 1983 Jun 2;308(22):1312–1318. doi: 10.1056/NEJM198306023082202. [DOI] [PubMed] [Google Scholar]
  2. Cowley M. J., Hastillo A., Vetrovec G. W., Hess M. L. Effects of intracoronary streptokinase in acute myocardial infarction. Am Heart J. 1981 Dec;102(6 Pt 2):1149–1158. doi: 10.1016/0002-8703(81)90646-3. [DOI] [PubMed] [Google Scholar]
  3. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  4. Dewhurst N. G., Muir A. L. Comparative prognostic value of radionuclide ventriculography at rest and during exercise in 100 patients after first myocardial infarction. Br Heart J. 1983 Feb;49(2):111–121. doi: 10.1136/hrt.49.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mathey D. G., Kuck K. H., Tilsner V., Krebber H. J., Bleifeld W. Non surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation. 1981 Mar;63(3):489–497. doi: 10.1161/01.cir.63.3.489. [DOI] [PubMed] [Google Scholar]
  6. Proceedings of the british cardiac society. Br Heart J. 1984 Jun;51(6):679–694. [PMC free article] [PubMed] [Google Scholar]
  7. Smith R. A., Dupe R. J., English P. D., Green J. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature. 1981 Apr 9;290(5806):505–508. doi: 10.1038/290505a0. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES